Selected research
Market Outlook & Growth Opportunities
Global Virus Transport Medium Market Outlook and Growth Opportunities 2026
Market perspective
The global Virus Transport Medium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Virus Transport Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Virus Transport Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Virus Transport Medium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Virus Transport Medium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Virus Transport Medium market include BD, Capricorn Scientific, Copan Diagnostics, FC-BIOS SDN BHD, Hardy Diagnostics, Liofilchem, Mantacc, Medical Wire & Equipment and Medico Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Virus Transport Medium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Virus Transport Medium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Virus Transport Medium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Virus Transport Medium market size, projected growth trends, production technologies, key applications, and end-use industries.
Virus Transport Medium Segment by Company
BD
Capricorn Scientific
Copan Diagnostics
FC-BIOS SDN BHD
Hardy Diagnostics
Liofilchem
Mantacc
Medical Wire & Equipment
Medico Technology
Ruhof
Teknova
Thermo Fisher Scientific
Bio-Med
Virus Transport Medium Segment by Type
Inactivate
Non Inactivate
Virus Transport Medium Segment by Application
University
Research Institute
Hospital
Other
Virus Transport Medium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Virus Transport Medium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Virus Transport Medium market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Virus Transport Medium significant trends, drivers, influence factors in global and regions.
6. To analyze Virus Transport Medium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virus Transport Medium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Virus Transport Medium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virus Transport Medium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Virus Transport Medium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Virus Transport Medium industry.
Chapter 3: Detailed analysis of Virus Transport Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Virus Transport Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Virus Transport Medium in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Inactivate
- Non Inactivate
Applications
- University
- Research Institute
- Hospital
- Other
Companies covered
- BD
- Capricorn Scientific
- Copan Diagnostics
- FC-BIOS SDN BHD
- Hardy Diagnostics
- Liofilchem
- Mantacc
- Medical Wire & Equipment
- Medico Technology
- Ruhof
- Teknova
- Thermo Fisher Scientific
- Bio-Med
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Virus Transport Medium Sales Value (2021-2032)
- 1.2.2 Global Virus Transport Medium Sales Volume (2021-2032)
- 1.2.3 Global Virus Transport Medium Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Virus Transport Medium Market Dynamics
- 2.1 Virus Transport Medium Industry Trends
- 2.2 Virus Transport Medium Industry Drivers
- 2.3 Virus Transport Medium Industry Opportunities and Challenges
- 2.4 Virus Transport Medium Industry Restraints
3 Virus Transport Medium Market by Company
- 3.1 Global Virus Transport Medium Company Revenue Ranking in 2025
- 3.2 Global Virus Transport Medium Revenue by Company (2021-2026)
- 3.3 Global Virus Transport Medium Sales Volume by Company (2021-2026)
- 3.4 Global Virus Transport Medium Average Price by Company (2021-2026)
- 3.5 Global Virus Transport Medium Company Ranking (2024-2026)
- 3.6 Global Virus Transport Medium Company Manufacturing Base and Headquarters
- 3.7 Global Virus Transport Medium Company Product Type and Application
- 3.8 Global Virus Transport Medium Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Virus Transport Medium Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Virus Transport Medium Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Virus Transport Medium Market by Type
- 4.1 Virus Transport Medium Type Introduction
- 4.1.1 Inactivate
- 4.1.2 Non Inactivate
- 4.2 Global Virus Transport Medium Sales Volume by Type
- 4.2.1 Global Virus Transport Medium Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Virus Transport Medium Sales Volume by Type (2021-2032)
- 4.2.3 Global Virus Transport Medium Sales Volume Share by Type (2021-2032)
- 4.3 Global Virus Transport Medium Sales Value by Type
- 4.3.1 Global Virus Transport Medium Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Virus Transport Medium Sales Value by Type (2021-2032)
- 4.3.3 Global Virus Transport Medium Sales Value Share by Type (2021-2032)
5 Virus Transport Medium Market by Application
- 5.1 Virus Transport Medium Application Introduction
- 5.1.1 University
- 5.1.2 Research Institute
- 5.1.3 Hospital
- 5.1.4 Other
- 5.2 Global Virus Transport Medium Sales Volume by Application
- 5.2.1 Global Virus Transport Medium Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Virus Transport Medium Sales Volume by Application (2021-2032)
- 5.2.3 Global Virus Transport Medium Sales Volume Share by Application (2021-2032)
- 5.3 Global Virus Transport Medium Sales Value by Application
- 5.3.1 Global Virus Transport Medium Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Virus Transport Medium Sales Value by Application (2021-2032)
- 5.3.3 Global Virus Transport Medium Sales Value Share by Application (2021-2032)
6 Virus Transport Medium Regional Sales and Value Analysis
- 6.1 Global Virus Transport Medium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Virus Transport Medium Sales by Region (2021-2032)
- 6.2.1 Global Virus Transport Medium Sales by Region: 2021-2026
- 6.2.2 Global Virus Transport Medium Sales by Region (2027-2032)
- 6.3 Global Virus Transport Medium Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Virus Transport Medium Sales Value by Region (2021-2032)
- 6.4.1 Global Virus Transport Medium Sales Value by Region: 2021-2026
- 6.4.2 Global Virus Transport Medium Sales Value by Region (2027-2032)
- 6.5 Global Virus Transport Medium Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Virus Transport Medium Sales Value (2021-2032)
- 6.6.2 North America Virus Transport Medium Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Virus Transport Medium Sales Value (2021-2032)
- 6.7.2 Europe Virus Transport Medium Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Virus Transport Medium Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Virus Transport Medium Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Virus Transport Medium Sales Value (2021-2032)
- 6.9.2 South America Virus Transport Medium Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Virus Transport Medium Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Virus Transport Medium Sales Value Share by Country, 2025 VS 2032
7 Virus Transport Medium Country-level Sales and Value Analysis
- 7.1 Global Virus Transport Medium Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Virus Transport Medium Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Virus Transport Medium Sales by Country (2021-2032)
- 7.3.1 Global Virus Transport Medium Sales by Country (2021-2026)
- 7.3.2 Global Virus Transport Medium Sales by Country (2027-2032)
- 7.4 Global Virus Transport Medium Sales Value by Country (2021-2032)
- 7.4.1 Global Virus Transport Medium Sales Value by Country (2021-2026)
- 7.4.2 Global Virus Transport Medium Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.9.2 France Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.16.2 China Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.19.2 India Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Virus Transport Medium Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Virus Transport Medium Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Virus Transport Medium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.1.4 BD Virus Transport Medium Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 Capricorn Scientific
- 8.2.1 Capricorn Scientific Company Information
- 8.2.2 Capricorn Scientific Business Overview
- 8.2.3 Capricorn Scientific Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Capricorn Scientific Virus Transport Medium Product Portfolio
- 8.2.5 Capricorn Scientific Recent Developments
- 8.3 Copan Diagnostics
- 8.3.1 Copan Diagnostics Company Information
- 8.3.2 Copan Diagnostics Business Overview
- 8.3.3 Copan Diagnostics Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Copan Diagnostics Virus Transport Medium Product Portfolio
- 8.3.5 Copan Diagnostics Recent Developments
- 8.4 FC-BIOS SDN BHD
- 8.4.1 FC-BIOS SDN BHD Company Information
- 8.4.2 FC-BIOS SDN BHD Business Overview
- 8.4.3 FC-BIOS SDN BHD Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.4.4 FC-BIOS SDN BHD Virus Transport Medium Product Portfolio
- 8.4.5 FC-BIOS SDN BHD Recent Developments
- 8.5 Hardy Diagnostics
- 8.5.1 Hardy Diagnostics Company Information
- 8.5.2 Hardy Diagnostics Business Overview
- 8.5.3 Hardy Diagnostics Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Hardy Diagnostics Virus Transport Medium Product Portfolio
- 8.5.5 Hardy Diagnostics Recent Developments
- 8.6 Liofilchem
- 8.6.1 Liofilchem Company Information
- 8.6.2 Liofilchem Business Overview
- 8.6.3 Liofilchem Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Liofilchem Virus Transport Medium Product Portfolio
- 8.6.5 Liofilchem Recent Developments
- 8.7 Mantacc
- 8.7.1 Mantacc Company Information
- 8.7.2 Mantacc Business Overview
- 8.7.3 Mantacc Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Mantacc Virus Transport Medium Product Portfolio
- 8.7.5 Mantacc Recent Developments
- 8.8 Medical Wire & Equipment
- 8.8.1 Medical Wire & Equipment Company Information
- 8.8.2 Medical Wire & Equipment Business Overview
- 8.8.3 Medical Wire & Equipment Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Medical Wire & Equipment Virus Transport Medium Product Portfolio
- 8.8.5 Medical Wire & Equipment Recent Developments
- 8.9 Medico Technology
- 8.9.1 Medico Technology Company Information
- 8.9.2 Medico Technology Business Overview
- 8.9.3 Medico Technology Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Medico Technology Virus Transport Medium Product Portfolio
- 8.9.5 Medico Technology Recent Developments
- 8.10 Ruhof
- 8.10.1 Ruhof Company Information
- 8.10.2 Ruhof Business Overview
- 8.10.3 Ruhof Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Ruhof Virus Transport Medium Product Portfolio
- 8.10.5 Ruhof Recent Developments
- 8.11 Teknova
- 8.11.1 Teknova Company Information
- 8.11.2 Teknova Business Overview
- 8.11.3 Teknova Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Teknova Virus Transport Medium Product Portfolio
- 8.11.5 Teknova Recent Developments
- 8.12 Thermo Fisher Scientific
- 8.12.1 Thermo Fisher Scientific Company Information
- 8.12.2 Thermo Fisher Scientific Business Overview
- 8.12.3 Thermo Fisher Scientific Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Thermo Fisher Scientific Virus Transport Medium Product Portfolio
- 8.12.5 Thermo Fisher Scientific Recent Developments
- 8.13 Bio-Med
- 8.13.1 Bio-Med Company Information
- 8.13.2 Bio-Med Business Overview
- 8.13.3 Bio-Med Virus Transport Medium Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Bio-Med Virus Transport Medium Product Portfolio
- 8.13.5 Bio-Med Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Virus Transport Medium Value Chain Analysis
- 9.1.1 Virus Transport Medium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Virus Transport Medium Sales Mode & Process
- 9.2 Virus Transport Medium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Virus Transport Medium Distributors
- 9.2.3 Virus Transport Medium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst